CRP and chronic kidney disease: CALIBRA overcomes inherent limitations of existing CVD risk scores in forecasting CV events among NDD-CKD patients by making use of both traditional and CKD-specific risk factors (i.e. kidney function measures eGFR (10), albuminuria (9, 29) or proteinuria (10, 11), uric acid (9), C-reactive protein (30), among others).